Comparison Between Endoscopic Macroscopic Classification and F-18 FDG PET Findings in Gastric Mucosa–Associated Lymphoid Tissue Lymphoma Patients
暂无分享,去创建一个
K. Ohshima | S. Kurata | H. Kaida | M. Ishibashi | N. Hayabuchi | K. Nakahara | Shunji Arikawa | Yasumitsu Hirose | J. Uozumi | Keita Nakahara
[1] J. Trotman,et al. Role of early PET in the management of diffuse large B-cell lymphoma , 2010, Current opinion in oncology.
[2] R. Tsang,et al. Long‐term outcome in localized extranodal mucosa‐associated lymphoid tissue lymphomas treated with radiotherapy , 2010, Cancer.
[3] Ora Israel,et al. 18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients , 2010, Journal of Nuclear Medicine.
[4] R. Fujita,et al. Significance of 18F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography , 2009, Annals of nuclear medicine.
[5] J. Hatazawa,et al. Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings , 2008, Annals of nuclear medicine.
[6] D. Fischer,et al. FDG avidity and PET/CT patterns in primary gastric lymphoma , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[7] A. Chott,et al. Pathology and clinical course of MALT lymphoma with plasmacytic differentiation. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] O. Bairey,et al. Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma , 2007, European journal of haematology.
[9] Sigrid Stroobants,et al. Revised response criteria for malignant lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] A. Chott,et al. 18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] Te-Chun Hsieh,et al. Positive Correlation Between Standardized Uptake Values of FDG Uptake in the Stomach and the Value of the C-13 Urea Breath Test , 2006, Clinical nuclear medicine.
[12] U. Jaeger,et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] T. Akamatsu,et al. Comparison of Localized Gastric Mucosa‐Associated Lymphoid Tissue (MALT) Lymphoma with and without Helicobacter pylori Infection , 2006, Helicobacter.
[14] S. Faria,et al. Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose. , 2005, World journal of gastroenterology.
[15] Y. Erdi,et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] U. Jaeger,et al. High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-up , 2005, Clinical Cancer Research.
[17] K. Beal,et al. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] M. Seto,et al. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration , 2003, Journal of gastroenterology.
[19] A. Alavi,et al. Utility of FDG-PET scanning in lymphoma by WHO classification. , 2003, Blood.
[20] R. Hustinx,et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] M E Phelps,et al. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] B. Coiffier,et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[23] A. Hart,et al. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] T. Radaszkiewicz,et al. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. , 1992, Gastroenterology.
[25] P. Isaacson,et al. Malignant lymphoma of mucosa‐associated lymphoid tissue. A distinctive type of B‐cell lymphoma , 1983, Cancer.
[26] L. Medeiros,et al. Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) , 2013 .
[27] M. Kojima,et al. The usefulness of 18F‐fluorodeoxyglucose positron emission tomography (18F‐FDG‐PET) and a comparison of 18F‐FDG‐pet with 67gallium scintigraphy in the evaluation of lymphoma , 2022 .